PPC Budget | # Keywords | # Overlap kw | ||
---|---|---|---|---|
prescriptiontreatmentwebsite | $784,154 | 110,530 | 62 | Learn More |
livewellwithlungcancer.com | $678 | 169 | 16 | Learn More |
info.com | $344,734 | 183,489 | 14 | Learn More |
abcam.com | $5,887 | 2,268 | 12 | Learn More |
thermofisher.com | $14,282 | 13,238 | 8 | Learn More |
Organic Listings | 1st Page Keywords | Avg Pos | Pos Trend | Est.Traffic | Traffic Value | |
---|---|---|---|---|---|---|
The Role of PD-L1 Inhibitors in Immunotherapy - AZ Immuno-Oncology https://www.azimmuno-oncology.Durvalumab (antiPD-L1 antibody | 14 | 11.63 ( 3.38 ) | 6710 | $134 | ||
Keyword | Position | Trend | Search Vol | CPC | ||
pdl 1 | 15 ( 3 ) | 320 | $8.79 | |||
pd-1 ligand | 7.5 ( 2.5 ) | 30 | $9.48 | |||
anti pdl1 | 8 ( 1 ) | 320 | $9.52 | |||
pd 1 ligand | 9 ( 6 ) | 30 | $9.48 | |||
anti-pd-l1 | 11 ( 4.5 ) | 110 | $5.49 | |||
Role of CTLA-4 Inhibitors in Immunotherapy - AZ Immuno-Oncology https://www.azimmuno-oncology.Tremelimumab, an investigation | 9 | 8.64 ( 5.36 ) | 5370 | $75 | ||
Keyword | Position | Trend | Search Vol | CPC | ||
ctla4 | 9 ( 2 ) | 1,000 | $7.56 | |||
anti ctla4 | 19 ( 9 ) | 70 | $9.67 | |||
ctla - 4 | 5 ( 1 ) | 1,300 | $6.27 | |||
ctla-4 | 6 | 1,300 | $6.27 | |||
ctla 4 | 9 ( 5 ) | 1,300 | $6.27 | |||
Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Educational Videos. New Approaches. Resource Library. Adverse Event Info. Clinical Data. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Resource Library. Educational Videos. Adverse Event Info. New Approaches. Clinical Data. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. New Approaches. Adverse Event Info. Clinical Data. Resource Library. Educational Videos. www.azimmuno-oncology.com/ Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Educational Videos. Clinical Data. New Approaches. Resource Library. Adverse Event Info. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ | |||
Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Educational Videos. Adverse Event Info. Clinical Data. New Approaches. Resource Library. www.azimmuno-oncology.com/ Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Resource Library. Adverse Event Info. Clinical Data. Educational Videos. New Approaches. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ CTLA-4 Inhibition - Physician Information Learn About How CTLA-4 Inhibition May Help Induce An Antitumor Immune Response. Clinical Data. www.azimmuno-oncology.com/ Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Adverse Event Info. Resource Library. New Approaches. Educational Videos. Clinical Data. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ | |||
Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. New Approaches. Adverse Event Info. Resource Library. Educational Videos. Clinical Data. www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Resource Library. Educational Videos. New Approaches. PD-L1 Testing. Clinical Data. Adverse Event Info. www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Educational Videos. Adverse Event Info. Resource Library. Clinical Data. New Approaches. www.azimmuno-oncology.com/ Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. New Approaches. Clinical Data. Educational Videos. Adverse Event Info. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ | |||
Official Physician Site - Bladder Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. New Approaches. Adverse Event Info. Clinical Data. Educational Videos. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ Official Physician Site - Bladder Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. Clinical Data. Adverse Event Info. New Approaches. Educational Videos. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. New Approaches. Clinical Data. Adverse Event Info. Educational Videos. Resource Library. www.azimmuno-oncology.com/ Official Physician Site - Bladder Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. Educational Videos. Adverse Event Info. Clinical Data. New Approaches. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ | |||
PD-L1 Inhibition - Official HCP Website Learn How PD-L1 Is Being Evaluated In Trials To Restore The Antitumor Response. www.azimmuno-oncology.com/ Official Physician Site - Bladder Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. Clinical Data. Educational Videos. New Approaches. Adverse Event Info. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ Immunotherapy For NSCLC - Official Physician Site Learn About The Potential In Treatment Evolution & View Areas Of Investigation. PD-L1 Testing. Educational Videos. Resource Library. Clinical Data. New Approaches. Adverse Event Info. www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Resource Library. Clinical Data. Adverse Event Info. New Approaches. Educational Videos. Types: IO In Various Cancers, imAE www.azimmuno-oncology.com/ | |||
Immunotherapy For NSCLC - Immuno-Oncology HCP Info Discover The Unmet Needs Of Stage III NSCLC & View Ongoing Clinical Research. Adverse Event Info. Resource Library. Educational Videos. New Approaches. Clinical Data. www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Clinical Data. PD-L1 Testing. Adverse Event Info. Educational Videos. New Approaches. Types: IO In Various Cancers, imAE Vi www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Adverse Event Info. Resource Library. Educational Videos. New Approaches. Clinical Data. Types: IO In Various Cancers, imAE www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Resource Library. Clinical Data. PD-L1 Testing. Adverse Event Info. New Approaches. Educational Videos. Types: IO In Variou www.azimmuno-oncology.com/ | |||
The Role Of STAT3 - Healthcare Professionals Learn About STAT3 Reduction And The Potential To Enhance Antitumor Immunity. Educational Videos. New Approaches. PD-L1 Testing. Clinical Data. Adverse Event Info. Types: IO In Various Cancers, imAE Vi www.azimmuno-oncology.com/ Official Physician Site - NSCLC Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. www.azimmuno-oncology.com/ Physician Information - Emerging Immunotherapy Options Read About The Promise Of Research & View Investigative Clinical Programs. PD-L1 Testing. Adverse Event Info. Resource Library. Educational Videos. New Approaches. Clinical Data. Types: IO In Various www.azimmuno-oncology.com/ Official Physician Site - Bladder Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. Resource Library. Clinical Data. Educational Videos. New Approaches. Adverse Event Info. www.azimmuno-oncology.com/ | |||
Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Clinical Data. Adverse Event Info. New Approaches. Educational Videos. Types: IO In Various Cancers, imAE Video, Pathway www.azimmuno-oncology.com/ Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Educational Videos. Adverse Event Info. New Approaches. Resource Library. Clinical Data. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Educational Videos. Clinical Data. PD-L1 Testing. Adverse Event Info. New Approaches. Types: IO In Various Cancers, imAE Vi www.azimmuno-oncology.com/ Official Physician Site - NSCLC Tumors & Immunotherapy Learn About The Potential In Treatment Evolution & View Areas Of Investigation. Clinical Data. New Approaches. Resource Library. Adverse Event Info. Educational Videos. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ | |||
Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Resource Library. Educational Videos. Clinical Data. Adverse Event Info. New Approaches. www.azimmuno-oncology.com/ Bladder Cancer Tumors - Physician Immunotherapy Info Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. New Approaches. Clinical Data. Resource Library. Adverse Event Info. Educational Videos. Types: IO In Various Cancers, i www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Educational Videos. Resource Library. Adverse Event Info. Clinical Data. New Approaches. Types: IO In Various Cancers, imAE www.azimmuno-oncology.com/ Immunotherapy For NSCLC - Immuno-Oncology HCP Info Discover The Unmet Needs Of Stage III NSCLC Treatment & View Clinical Studies. Resource Library. Clinical Data. Educational Videos. New Approaches. Adverse Event Info. Types: IO In Various Cancers, im www.azimmuno-oncology.com/ | |||
Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Adverse Event Info. Educational Videos. PD-L1 Testing. New Approaches. Clinical Data. Resource Library. Types: IO In Variou www.azimmuno-oncology.com/ Immuno-Oncology Information - Stage III NSCLC Information Physicians: Learn About The Potential Of Combination Immunotherapy In NSCLC. Clinical Data. New Approaches. Resource Library. Adverse Event Info. Educational Videos. PD-L1 Testing. www.azimmuno-oncology.com/ The Role Of STAT3 - Healthcare Professionals Learn About STAT3 Reduction And The Potential To Enhance Antitumor Immunity. Adverse Event Info. PD-L1 Testing. Clinical Data. New Approaches. Educational Videos. Types: IO In Various Cancers, imAE Vi www.azimmuno-oncology.com/ Bladder Cancer Learn About The Various Antitumor Approaches Being Explored For Bladder Cancer. Resource Library. Clinical Data. New Approaches. Adverse Event Info. PD-L1 Testing. Educational Videos. Types: IO In Var www.azimmuno-oncology.com/ | |||